Abstract:Introduction- DM is a chronic metabolic disease characterized by elevated blood sugar levels (hyperglycemia) caused by impaired insulin production, cellular insulin resistance, or both. DM is a systemic disease having severe microvascular and macrovascular complications. Diabetic nephropathy (DN), diabetic retinopathy, and diabetic neuropathy are examples of microvascular complications whereas stroke, cardiovascular diseases (CVDs), and peripheral vascular diseases are examples of macrovascular complications. DN is a common micro-angiopathic complication in patients with diabetes. Inammation plays a crucial role in the development and progression of DN, as many inammatory cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-8 (IL-18), and tumor necrosis factor α (TNF- ) contribute in the pathogenesis of DN. An increase in neutrophil count is seen in thrombus forming and ischemic diseases. The Neutrophil-Lymphocyte ratio (NLR) in complete blood count is studied in many cardiac and non-cardiac diseases as inammatory marker and is used to predict the prognosis. Serum ferritin concentration is usually increased in poorly controlled type 2 diabetic patients reecting increased oxidative stress. Objectives- To study the Neutrophil Lymphocyte ratio (NLR) and serum ferritin in patients of type 2 diabetes. Methods- A cross-sectional study was conducted on 150 patients with T2DM in SRN hospital, afliated to MLNMC, prayagraj. Blood samples were taken to estimate CBC, LFT, KFT, S. Electrolyte, HbA1C, FBS/PPBS, S. ferritin and urine for microalbumin. Data was collected, entered in MS Excel Spreadsheet & appropriate statistical package applied. Results- The median NLR of the type 2 DM patients was 2.10. Of total 150 diabetic patients 26 patients (17.3%) were having nephropathy based on urine microalbumin. Based on nephropathy in patients of T2DM, two groups (A and B) were made. Group A includes patients with nephropathy, while Group B includes patient without Nephropathy. The mean Hb, MCV, and ALC were lower in Group A (T2DM patients with nephropathy) patients. In contrast, TLC, Mean ANC and NLR were higher in Group A (T2DM patients with nephropathy) patients. NLR and haemoglobin show a signicant difference between both groups A and B. The mean S. ferritin levels were higher in Group A (T2DM patients with nephropathy) patients, difference was signicant between both groups. In the present study, NLR was negatively correlated with S. ferritin with r= - 0.092, and the correlation was insignicant. Conclusion- the results of our study showed that there was a signicant relation between NLR, S. ferritin and DN. Therefore, NLR and S. Ferritin may be considered as a novel surrogate marker of DN in early stages

Correlation between insulin resistance and the rate of neutrophils-lymphocytes, monocytes-lymphocytes, platelets-lymphocytes in type 2 diabetic patients

Relationship between Plasma Phospholipid Fatty Acid Profile and Insulin Resistance in Type 2 Diabetics

Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study

Association between neutrophil-to-lymphocyte ratio and diabetic retinopathy in patients with type 2 diabetes: a cohort study

The Relationship between Neutrophil-to-Lymphocyte Ratio and Intracerebral Hemorrhage in Type 2 Diabetes Mellitus

Low-Density Neutrophils Contribute to Subclinical Inflammation in Patients with Type 2 Diabetes

Neutrophil-to-lymphocyte ratio is associated with coronary microvascular dysfunction in type 2 diabetes mellitus patients

Investigation of neutrophil lymphocyte ratio and blood glucose regulation in patients with type 2 diabetes mellitus

Neutrophil-to-lymphocyte ratio associated with renal function in type 2 diabetic patients

Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio in patients with type 2 diabetes at different stages of diabetic retinopathy

Interaction between Erythrocyte Phospholipid Fatty Acids Composition and Variants of Inflammation-Related Genes on Type 2 Diabetes.

The Association between Neutrophil-to-Lymphocyte Ratio and Glycemic Control in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis

Serum N-3 Polyunsaturated Fatty Acid and High-sensitivity C Reactive Protein in Patients with Newly Diagnosed Type 2 Diabetes Mellitus

The Platelet-to-Lymphocyte Ratio Predicts Diabetic Retinopathy in Type 2 Diabetes Mellitus

Abstract 156: Study of Neutrophil Lymphocyte Ratio, Platelet Lymphocyte Ratio, RDW And Hba1c in Subject with Type 2 Diabetes Mellitus and Their Correlation with Diabetic Nephropathy and Retinopathy

Correlation Between Plasma NLRP3, IL-1β, and IL-18 and Diabetic Nephropathy in Patients With Type 2 Diabetes

Correlation of neutrophil–lymphocyte ratio with carotid intima–media thickness in diabetes-an analytical cross-sectional study

A NOVEL DIAGNOSTIC APPROACH: NEUTROPHIL LYMPHOCYTE RATIO AND SERUM FERRITIN IN TYPE 2 DIABETES PATIENTS WITH DIABETIC NEPHROPATHY

Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease

Association of the systemic immuno-inflammation index, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio with diabetic microvascular complications

The Relationship Between Insulin Resistance Neutrophil to Lymphocyte Ratio